Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
BMC Cancer. 2018;18(1): 
Concurrent Chemoradiotherapy with S-1 Compared with Concurrent Chemoradiotherapy with Docetaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma
. 2020;
Long-term results of definitive concurrent chemoradiotherapy using paclitaxel plus oxaliplatin in unresectable locally advanced esophageal cancer: a prospective phase II trial
Cancer Medicine. 2016;5(12):3371-3377
A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer
Indian Journal of Medical and Paediatric Oncology. 2014;35(01):54-59
Tu1217 - Clinical Predictors of Concurrent Chemoradiotherapy Response and Survival for Locally Advanced and Advanced Esophageal Cancer
Gastroenterology. 2018;154(6):S-907
Dosimetric Predictors of Cardiac Events After Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer
International Journal of Radiation Oncology*Biology*Physics. 2021;111(3):S102
Toxicity data for preoperative concurrent chemoradiotherapy with oxaliplatin and continuous infusion 5-fluorouracil for locally advanced esophageal cancer
Diseases of the Esophagus. 2010;24(5):330-336
Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer
The Journal of the Korean Society for Therapeutic Radiology and Oncology. 2011;29(1):20
PD-047 Concurrent chemoradiotherapy in locally advanced non-smallcell lung cancer — do the guidelines match the evidence?
Lung Cancer. 2005;49:S80
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
Radiation Oncology. 2021;16(1):